×

img Acces sibility Controls

Research Projects Banner

Research Projects

SREBP inhibitors as novel therapeutics for non-alcoholic fatty liver disease: Insights on CRISPER-Cas9 inhibition of SREBPs targeting activated hepatic stellate cells

Implementing Organization

Central Food Technological Research Institute (CFTRI)
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad
Principal Investigator
Dr P. Madan Kumar
Scientist
|
Central Food Technological Research Institute (CFTRI)

About

Objective: Evaluating the role of SREBPs and SREBP inhibition in experimental model of NAFLD using ApoE deficient mice. Histological and immunohistochemical analysis of the fatty liver. Determining the effect of SREBP inhibition in HSCs and food bioactive binding induced changes in SREBP stability. Determining the initial toxicity, nutridynamics and nutrikinetics of food SREBP inhibitors. Determining the initial toxicity, nutridynamics and nutrikinetics of food SREBP inhibitors. Determining the effect of SREBP inhibition in HSCs and food bioactive binding induced changes in SREBP stability. Histological and immunohistochemical analysis of the fatty liver. Evaluating the role of SREBPs and SREBP inhibition in experimental model of NAFLD using ApoE deficient mice.

Funding Organization
Funding Organization
Council of Scientific and Industrial Research
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Non-alcoholic fatty liver disease
Start Year
2020
End Year
2023
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop